Cook Medical, a large Indiana-based medical device supplier in the United States, is facing more than 500 medical device claims filed against it with regard to its inferior vena cava (IVC) filters, which are small, cage-like medical devices that are implanted in patients to prevent blood clots from migrating to the lungs of at-risk patients who would otherwise be at greater risk for pulmonary embolism. There are more than 600,000 clinically significant pulmonary embolisms that are responsible for more than 200,000 deaths in the United States every year .
More than 200,000 IVC filters are implanted in patients in the United States each year, and represents a $435 million market in the United States.
As of last summer, about 100 IVC filter claims had been filed against Cook Medical. By this summer, about 560 IVC claims had been filed. Cook Medical is one of the three leading suppliers of IVC filters in the United States – the other two are C.R. Bard, which is based in New Jersey and is facing IVC filter cases filed in the U.S. District Court in Arizona, and Cordis, which is a subsidiary of Johnson & Johnson that is also based in New Jersey. Cook Medical is one of Indiana’s largest private employers, with annual sales of $2 billion and a workforce of 12,000 worldwide.
IVC filter claims include filters that are breaking after being implanted in patients, IVC filters that have migrated from the point of implantation to other parts of the body, and IVC filters that have penetrated blood vessels, resulting in IVC filter patients experiencing pain and having to undergo additional surgeries to recover the medical devices and/or repair harm done by the filters. Some patients have suffered serious infections as a result.
Cook Medical’s medical device business is also facing other claims of supplying defective products, including five recalls since 2014, the most recent of which occurred in May 2016 when it recalled more than 4 million catheters after receiving reports that tips on some of the catheters were breaking or splitting, which required surgery for removal.
According to the FDA, the incidence of pulmonary embolism (PE) in patients with deep venous thrombosis (DVT) is 19% to 28%. Treatment of PE has been shown to be effective in reducing the mortality from 30% to 8%. Normally, patients with DVT and/or PE are treated with anticoagulation therapy. However, in some patients anticoagulation is ineffective, contraindicated, or results in complications which require that it be discontinued. For these patients, vena caval interruption with a filter is recommended. The goal of filter placement is to try to obtain high filtering efficiency (large and small emboli) without impedance of blood flow and with reduced device related thrombosis while minimizing migration and without penetration of the vessel wall.
If you or a loved one were seriously injured (or worse) due to a Cook Medical IVC filter, or an IVC filter supplied by another IVC filter manufacturer, you should promptly find a defective medical device claim lawyer who may investigate your IVC filter claim for you and represent you in a claim for compensation due to the harm you or your loved one suffered as a result of a defective IVC filter.
Visit our website or call us toll-free in the United States at 800-295-3959 to find IVC filter claim lawyers (defective medical device claim lawyers) in your state who may assist you.
Turn to us when you don’t know where to turn.